Cipla Primes For US Momentum But Seretide Generic Is Slow In UK

 
• By Anju Ghangurde

Cipla reported a strong second quarter, with management upbeat about building momentum in the US business with a “good mix” of differentiated launches. The ramp-up of the firm’s Seretide generic in the UK, though, appears slow.

Pharma pills
CIPLA IS UPPING ITS PLAY IN THE US MARKET

More from Earnings

More from Business